Inadvertent Metal Loading of Critically Ill Patients with Acute Renal Failure by Human Albumin Solution Infusion Therapy

References

• Metalle in der Umwelt, E. Merian. Verlag Chemie, Weinheim 1984; 301, pp. 409, pp. 425, pp. 471, pp. 487.
   Google Scholar
• Sneddon J. M. Trace metals in food (Editorial). Human Toxicol. 1986; 5: 219–220
   PubMedGoogle Scholar
• Francois B., Leyssens L., Gerard P., Bachy A., Battisti O. Contaminations in blood of infants on prolonged intravenous therapy. Lancet 1986; i: 380–381
   Google Scholar
• Fell G. S., Shenkin A., Halls D. J., Wells J. C.K. Aluminium contamination of intravenous pharmaceuticals, nutrients, and blood products. Lancet 1986; i: 380
   Google Scholar
• Fell G. S., Maharaj D. Trace metal contamination of albumin solutions used for plasma exchange. Lancet 1986; ii: 467–468
   Google Scholar
• Milliner D. S., Shinaberger J. H., Shumann P., Coburu J. W. Inadvertent aluminium administration during plasma exchange due to aluminium contamination of albumin-replacement solutions. N. Enql. J. Med. 1985; 312: 165–167
   PubMed Web of Science ®Google Scholar
• Nack Ch. N., Sundermase F. W. Nickel contamination of human serum albumin solutions. N. Enal. J. Med. 1985; 312: 1232
   Google Scholar
• Loeliger E. A., de Wolff F. A. Aluminium contamination of albumin replacement solutions. N. Enal. J. Med. 1985; 312: 1389
   PubMed Web of Science ®Google Scholar
• Maher E. R., Brown E. A., Curtis J. R., Phillips M. E., Sampson B. Accumulation of aluminium in chronic renal failure due to administration of albumin replacement solutions. Br. Med. J. 1986; 292: 306
   PubMed Web of Science ®Google Scholar
• Wilhelm M., Sprenger K. BG., Vossas U., Ohnesorg F. K. Aluminium load in chronic intermittent plasma exchange. Clin. Toxicol. 1987; 23: 209–220
   Google Scholar
• Davenport A., Roberts N. B. Serum aluminium levels in acute renal failure. Lancet 1986; ii: 1397–1398
   Google Scholar
• Baselt R. C. Disposition of toxic drugs and chemicals in man. Biomédical Publications, Davis (CA) 1982; 26, 105, 177, 191, 204, 420, 449, 546, 782.
   Google Scholar
• Hörl W. H., Haag M., Kuhlmann M., Wanner C. Posttraumatic and postoperative acute renal failure: Pathobiochemistry and therapy. Intensivmed. 1987; 24: 224–228
   Google Scholar
• Alfrey I. C. The dialysis encephalopathy syndrome. N. Enql. J. Med. 1976; 294: 184–187
   PubMed Web of Science ®Google Scholar
• Kerr D. N.S., Ward M. K. The history of aluminium related disease. 1, b) P. Garrett, M. O'Connor, P. Dervan, D. Mulcahy, J.F. Donohoe, M. Carmody, and W.F. O'Dwyer, Strategy for diagnosis and management of aluminium intoxication, p. 15. c) u. tjrancaccio, u. tsugiam, u. facini, j. Bisceglia, P. Padovese, M. Gallieni, M. Surian, S. Costantini, R. Giordano, M. Baruffaldi, and A. Berlin, Blood brain barrier derangement in aluminium intoxicated dialysis patients, p. 19. d)M.R. Wills and J. Savory, Aluminium homeostasis, p. 24. e)J. Savory, S. Brown, R.L. Bertholf, and M.R. Wills, Quantitative determination of aluminium, p. 246. f)A. Taylor, B. Starkey, and A.W. Walker, Measurement of aluminium-quality of analytical results, p. 260. g)O. Guillard and A. Pineau, The measurement of aluminium by the worldwide inter-laboratory quality control aluminium study: distribution and utilization of the results, p. 283. h) J. Pybus, Sources of variation in the measurement of aluminium in serum, water and dialysate, p. 292. i) G.S. Fell, Trace metals in renal failure, p. 325. j) A.C.T. Leung, I.S. Henderson, A.C. Kennedy, D.J. Halls, and G.S. Fell, Chromium transfer studies in haemodialysis and continuous ambulatory peritoneal dialysis (CAPD), p. 332. k) D.J. Halls, A.C.T. Leung, I.S. Henderson, G.S. Fell, and A.C. Kennedy, Serum and hair chromium levels in patients with renal failure, p. 337 in: A. Taylor (Ed.), Aluminium and other trace elements in renal disease, Baillière Tundall, London 1986.
   Google Scholar
• Koch H., Reich H., Franke D. Aluminium toxicity in uremic babies. Lancet 1985; ii: 831
   Google Scholar
• McGraw M., Bishop N., Jameson R., et al. Aluminium content of milk formulae and intravenousfluids used in infants. Lancet 1986; i: 157
   Google Scholar
• Andreoli S. P., Bergstein J. M., Sherraard D. J. Aluminium intoxication from aluminium-containing phosphate binders in children with azotemia not undergoing dialysis. N. Enal. J. Med. 1984; 310: 1079–1084
   PubMed Web of Science ®Google Scholar
• Nordal K. P., Talseth T., Dahl E., Attramadal A., Albrechtsen D., Halse J., Brodwall E. K., Flatmask A. Aluminium overload, a predisposing condition for epileptic seizures in renal-transplant patients treated with cyclosporin?. Lancet 1985; i: 154–155
   Google Scholar
• Candy J. M., Klimowski J., Perry R. H., et al. Aluminiumsilicates and senile plague formation in Alzheimer disease. Lancet 1986; i: 354–357
   Google Scholar
• Davenport A., Ahmad R. Serum aluminium and phosphate concentrations in CAPD. Lancet 1986; ii: 640
   Google Scholar
• Perl D. P., Good P. F. Uptake of aluminium into central nervous system along nasal-olfactory pathways. Lancet 1987; i: 1028
   Google Scholar
• Freundlich M., Zilleruds G., Abitol C., et al. Infant formula as a cause of aluminium toxicity in neonatal uremia. Lancet 1985; ii: 527–529
   Google Scholar
• Swartz R., Dombrouski J., Burnatowska-Heidin M., Mayor G. Microcytic anemia in dialysis patients: reversible marker of aluminium toxicity. Am. J. Kidnev Pis. 1987; 1: 217–223
   Google Scholar
• Altmann P., Al-Salihi F., Butter K., Cutler P., Blair J., Leeming R., Cunningham J., Marsh F. Serum aluminium levels and erythrocyte dihydropteridine reductase activity in patients on hemodialysis. N. Enal. J. Med. 1987; 3JJ7: 80–84
   Google Scholar
• Altmann P., Cunningham J., Blair J., Marsh F. Aluminium and dihydropteridine reductase in dialysis patients. N. Enql. J. Med. 1987; 317: 1605–1606
   Google Scholar
• Wheeler D. C., Smith B., Walls J. Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia. Lancet 1986; 1380
   PubMedGoogle Scholar
• O'Hare J. A., Murnaghan D. J. Reversal of aluminium-induced hemodialysis anemia by low-aluminium dialysate. N. Enql. J. Med. 1982; 306: 654–656
   PubMed Web of Science ®Google Scholar
• Altmann P., Butter K. C., Plowman D., Chaput de Saintonge D. M., Cunningham J., Marsh F. P. Residual renal function in hemodialysis patients may protect against hyperaluminemia. Kidney Int. 1987; 32: 710–713
   PubMed Web of Science ®Google Scholar
• Adam L., Hainline B. W., Zackson D. H. The importance of accurate and precise aluminium levels. N. Enal. J. Med. 1986; 313: 1609
   Web of Science ®Google Scholar
• Altmann P., Plowman D., Marsh F., Cunningham J. Aluminium chelation therapy in dialysis patients: evidence for inhibition of haemoglobin synthesis by low levels of aluminium. Lancet 1988i; 1012–1015
   PubMedGoogle Scholar
• Rubanyi G., Ligeti L., Koller A., Kovach A. G.B. Nickel ions and ischémie coronary vasoconstriction. Bibl. Cardiol. 1984; 38: 200–208
   PubMedGoogle Scholar
• Adkins B., Richards J. H., Gardner D. E. Enhancement of experimental respiratory infections following nickel inhalation. Environ. Res. 1979; 2Û: 33–42
   Google Scholar
• Graham J. A., Gardner D. E., Waters M. D., Loffin D. L. Effect of trace metals on phagocytosis of alveolar macrophages. Infect. Immun. 1979; 11: 1278–1283
   Google Scholar
• Graham J. A., Miller F. J., Daniels M. J., Payne E. A., Gardner D. E. Influence of Cd, Ni, and Cr on primary immunity in mice. Environ. Res. 1978; 16: 77–87
   PubMed Web of Science ®Google Scholar
• Spurenelemente, H. Zumkley. Georg Thieme, Stuttgart-New York 1983; 43, 75, 98, 108, 128, 140, 168, 197, 230
   Google Scholar